Masimo (MASI) Cash from Investing Activities Growth (1y) (2011 - 2026)
Masimo (MASI) Cash from Investing Activities Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -4,224.26% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 95.53% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 3.20% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -18.20% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -208.79% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -514.25% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -187.82% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -397.90% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -211.17% |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | -127.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -127.10% |
| Jan 3, 2026 | -188.78% |
| Sep 27, 2025 | 80.08% |
| Jun 28, 2025 | -145.37% |
| Mar 29, 2025 | 182.01% |
| Dec 28, 2024 | 138.74% |
| Sep 28, 2024 | -18.75% |
| Jun 29, 2024 | 148.21% |
| Mar 30, 2024 | -70.27% |
| Dec 30, 2023 | -10.96% |
| Sep 30, 2023 | -190.91% |
| Jul 1, 2023 | 97.77% |
| Apr 1, 2023 | 53.56% |
| Dec 31, 2022 | -152.61% |
| Apr 2, 2022 | -128.16% |
| Apr 3, 2021 | 31.93% |
| Sep 26, 2020 | -122.59% |
| Jun 27, 2020 | -33.67% |
| Mar 28, 2020 | 91.81% |
| Dec 28, 2019 | -140.87% |